Articles

How to navigate loss of exclusivity with a strategic commercial playbook

Download the playbook to learn how leading organizations prepare for and manage loss of exclusivity.

Meet Acumetis at World EPA 2027!

Meet the Acumetis GVA team at World EPA 2027 in Amsterdam as a Platinum Sponsor, exploring evidence, pricing, reimbursement, and access strategies across global markets.

Meet Acumetis at ISPOR EU 2026!

Meet Acumetis at ISPOR EU 2026 in Vienna. From PICO development and Joint Clinical Assessments to HEOR and market access, discover how Acumetis helps organizations turn evidence into value.

Transforming field reimbursement managers: reactive to proactive strategic enablement

Learn how proactive, data-driven solutions help reduce access barriers, improve account planning, and accelerate patient onboarding.

Advancing patient-centered medical publications through publication extenders

At ISMPP 2025, a clear imperative emerged: the future of medical publications reporting must be more inclusive, accessible, and patient-centered. Read the article here

How the obesity market evolution is reshaping payer strategies and forecasts

Explore how the obesity market is evolving as innovation, payer expectations, digital access, and patient demand reshape coverage strategies, forecasting, and long-term market success.

How patient services best-in-class benchmarking improves patient access

Discover how patient services benchmarking helps identify access barriers, improve operations, and optimize investment to enhance therapy initiation, adherence, and patient outcomes.

HUB and specialty pharmacy optimization support

Discover how patient services benchmarking helps identify access barriers, improve operations, and optimize investment to enhance therapy initiation, adherence, and patient outcomes.

Spain has just redrawn the rules of health technology assessment

Explore how Spain’s new health technology assessment framework is reshaping market access, evidence strategy, pricing decisions and lifecycle planning.